Absci ABSI
NASDAQ ABSI
$8.83 +0.03 (+0.34%)
As of: Sep 4, 2026 · 2:38 PM EDT

Absci (ABSI) Cash & Current Investments (2020 - 2026)

Absci (ABSI) posted Cash & Current Investments of $125.7 million for Q1 2026, down 12.88% sequentially from $144.3 million in Q4 2025, and down 6.18% YoY from $134.0 million in Q1 2025.

Analysis

Absci (ABSI) Cash & Current Investments (2020 - 2026) Analysis & Trends

Absci has reported Cash & Current Investments for 7 years, with the latest figure at $125.7 million in Q1 2026.

  • Quarterly Cash & Current Investments fell 6.18% year-over-year to $125.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $125.7 million (down 6.18% YoY) and the FY2025 annual result came in at $144.3 million, up 28.35% from the prior year.
  • Cash & Current Investments retreated to $125.7 million in Q1 2026 per ABSI's latest filing, from $144.3 million in the prior quarter.
  • Over five years, Cash & Current Investments peaked at $226.0 million in Q1 2022 and troughed at $50.0 million in Q2 2022.
  • A 5-year average of $136.6 million and a median of $134.0 million in 2025 frame the typical range for Cash & Current Investments.
  • The sharpest annual moves came in 2022 and 2023: Cash & Current Investments sank 49.72% in 2022, then jumped 149.16% in 2023.
  • Over 5 years, Cash & Current Investments stood at $164.4 million in 2022, then plunged by 40.61% to $97.7 million in 2023, then grew by 15.12% to $112.4 million in 2024, then advanced by 28.35% to $144.3 million in 2025, then dropped by 12.88% to $125.7 million in 2026.
  • According to Business Quant data, Cash & Current Investments over the past three periods registered $125.7 million, $144.3 million, and $152.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Vertex Pharmaceuticals 138.74 Bn 130.89 Bn 2.84 Bn 7.85 Bn
2 Regeneron Pharmaceuticals 85.52 Bn 77.52 Bn 3.93 Bn 7.99 Bn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn 5.18 Bn
4 Moderna 58.04 Bn 52.91 Bn 52.00 Mn 5.14 Bn
5 Revolution Medicines 44.06 Bn 44.06 Bn - -
6 BeOne Medicines 39.98 Bn 34.88 Bn 1.53 Bn 5.10 Bn
7 Alnylam Pharmaceuticals 35.46 Bn 32.15 Bn 992.69 Mn 3.31 Bn
8 Royalty Pharma 28.41 Bn 27.57 Bn - 836.99 Mn
9 Insmed 27.44 Bn 26.28 Bn 358.27 Mn 1.16 Bn
10 Absci 1.39 Bn 1.19 Bn - 201.14 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 201.14 Mn
Mar 31, 2026 125.71 Mn
Dec 31, 2025 144.29 Mn
Sep 30, 2025 152.48 Mn
Jun 30, 2025 117.46 Mn
Mar 31, 2025 133.98 Mn
Dec 31, 2024 112.43 Mn
Sep 30, 2024 127.07 Mn
Jun 30, 2024 145.25 Mn
Mar 31, 2024 161.54 Mn
Dec 31, 2023 97.66 Mn
Sep 30, 2023 113.48 Mn
Jun 30, 2023 124.59 Mn
Mar 31, 2023 144.26 Mn
Dec 31, 2022 164.43 Mn
Sep 30, 2022 181.31 Mn
Jun 30, 2022 206.02 Mn
Mar 31, 2022 226.00 Mn
Dec 31, 2021 252.57 Mn
Sep 30, 2021 279.26 Mn